BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12481421)

  • 21. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway.
    Rieger-Christ KM; Lee P; Zagha R; Kosakowski M; Moinzadeh A; Stoffel J; Ben-Ze'ev A; Libertino JA; Summerhayes IC
    Oncogene; 2004 Jun; 23(27):4745-53. PubMed ID: 15122336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the epidermal growth factor receptor inhibitor OSI-774, Tarceva, on downstream signaling pathways and apoptosis in human pancreatic adenocarcinoma.
    Ng SS; Tsao MS; Nicklee T; Hedley DW
    Mol Cancer Ther; 2002 Aug; 1(10):777-83. PubMed ID: 12492110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line.
    Sautin YY; Crawford JM; Svetlov SI
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C2010-9. PubMed ID: 11698260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells.
    Semba S; Itoh N; Ito M; Harada M; Yamakawa M
    Clin Cancer Res; 2002 Jun; 8(6):1957-63. PubMed ID: 12060641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine.
    Yokoi K; Fidler IJ
    Clin Cancer Res; 2004 Apr; 10(7):2299-306. PubMed ID: 15073105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation.
    Okano J; Gaslightwala I; Birnbaum MJ; Rustgi AK; Nakagawa H
    J Biol Chem; 2000 Oct; 275(40):30934-42. PubMed ID: 10908564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
    Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Kawagoe J; Takahashi K; Yada-Hashimoto N; Seino-Noda H; Sakata M; Motoyama T; Kurachi H; Testa JR; Tasaka K; Murata Y
    Clin Cancer Res; 2004 Nov; 10(22):7645-54. PubMed ID: 15569997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.
    Nakagami H; Morishita R; Yamamoto K; Taniyama Y; Aoki M; Matsumoto K; Nakamura T; Kaneda Y; Horiuchi M; Ogihara T
    Hypertension; 2001 Feb; 37(2 Pt 2):581-6. PubMed ID: 11230338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax.
    Somervaille TC; Linch DC; Khwaja A
    Blood; 2001 Sep; 98(5):1374-81. PubMed ID: 11520785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
    Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
    Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways.
    Klein JB; Rane MJ; Scherzer JA; Coxon PY; Kettritz R; Mathiesen JM; Buridi A; McLeish KR
    J Immunol; 2000 Apr; 164(8):4286-91. PubMed ID: 10754327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling associated with the induction of apoptosis.
    Marushige K; Marushige Y
    Anticancer Res; 1999; 19(5B):3865-71. PubMed ID: 10628325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.
    Brognard J; Clark AS; Ni Y; Dennis PA
    Cancer Res; 2001 May; 61(10):3986-97. PubMed ID: 11358816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.
    Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K
    Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.
    Smith JL; Schaffner AE; Hofmeister JK; Hartman M; Wei G; Forsthoefel D; Hume DA; Ostrowski MC
    Mol Cell Biol; 2000 Nov; 20(21):8026-34. PubMed ID: 11027273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Li RC; Gherardi E; Zhao G; Watson N; Sasisekharan R; Fan TP
    Circulation; 2003 Jun; 107(23):2955-61. PubMed ID: 12782568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
    Zhang D; Brodt P
    Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells.
    Wang Y; Kuramitsu Y; Baron B; Kitagawa T; Tokuda K; Akada J; Maehara SI; Maehara Y; Nakamura K
    Int J Oncol; 2017 Feb; 50(2):606-612. PubMed ID: 28000865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells.
    Matsumoto J; Kaneda M; Tada M; Hamada J; Okushiba S; Kondo S; Katoh H; Moriuchi T
    Jpn J Cancer Res; 2002 Dec; 93(12):1317-26. PubMed ID: 12495471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway.
    Lin MT; Lee RC; Yang PC; Ho FM; Kuo ML
    J Biol Chem; 2001 Dec; 276(52):48997-9002. PubMed ID: 11585835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.